Sitazit-M ER 500 Tablet

Опис товару

About Sitazit-M ER 500 Tablet

Sitazit-M ER 500 Tablet is a medication containing the active ingredient Sitagliptin, classified as Dipeptidyl Peptidase 4 Inhibitor. Sitagliptin, sold under the brand name Januvia among others, is an anti-diabetic medication used to treat type 2 diabetes. It is in the dipeptidyl peptidase-4 (DPP-4) inhibitor class and works by increasing the production of insulin and decreasing the production of glucagon by the pancreas.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Sitagliptin, the active ingredient in Sitazit-M ER 500 Tablet, belongs to the Dipeptidyl Peptidase 4 Inhibitor class. 1 INDICATIONS AND USAGE ZITUVIMET is a combination of sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and metformin hydrochloride (HCl), a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Sitazit-M ER 500 Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Sitazit-M ER 500 Tablet for extended periods without medical advice.